Indo Acidatama Past Earnings Performance
Past criteria checks 5/6
Indo Acidatama has been growing earnings at an average annual rate of 9.4%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 8.9% per year. Indo Acidatama's return on equity is 8.5%, and it has net margins of 5.9%.
Key information
9.4%
Earnings growth rate
9.4%
EPS growth rate
Chemicals Industry Growth | 9.0% |
Revenue growth rate | 8.9% |
Return on equity | 8.5% |
Net Margin | 5.9% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Indo Acidatama makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 1,056,266 | 61,915 | 141,713 | 0 |
31 Mar 24 | 1,029,841 | 61,231 | 145,095 | 0 |
31 Dec 23 | 1,026,705 | 58,018 | 144,829 | 0 |
30 Sep 23 | 1,044,487 | 76,137 | 147,157 | 0 |
30 Jun 23 | 1,035,354 | 54,268 | 145,423 | 0 |
31 Mar 23 | 1,013,128 | 43,354 | 138,293 | 0 |
31 Dec 22 | 977,708 | 33,640 | 132,378 | 0 |
30 Sep 22 | 899,619 | 15,735 | 113,636 | 0 |
30 Jun 22 | 901,035 | 19,507 | 110,429 | 0 |
31 Mar 22 | 878,278 | 19,462 | 105,221 | 0 |
31 Dec 21 | 907,833 | 26,543 | 106,494 | 0 |
30 Sep 21 | 959,236 | 31,369 | 118,776 | 0 |
30 Jun 21 | 886,624 | 28,578 | 109,004 | 0 |
31 Mar 21 | 894,408 | 33,302 | 105,567 | 0 |
31 Dec 20 | 890,997 | 44,152 | 108,172 | 0 |
30 Sep 20 | 808,400 | 38,892 | 109,536 | 0 |
30 Jun 20 | 779,108 | 42,405 | 108,822 | 0 |
31 Mar 20 | 725,098 | 42,942 | 109,279 | 0 |
31 Dec 19 | 683,576 | 42,829 | 98,764 | 0 |
30 Sep 19 | 659,761 | 38,525 | 92,682 | 0 |
30 Jun 19 | 652,509 | 41,229 | 89,424 | 0 |
31 Mar 19 | 631,816 | 43,903 | 84,287 | 0 |
31 Dec 18 | 600,987 | 38,735 | 80,001 | 0 |
30 Sep 18 | 563,360 | 39,677 | 71,999 | 0 |
30 Jun 18 | 522,481 | 32,631 | 70,558 | 0 |
31 Mar 18 | 533,794 | 26,449 | 70,521 | 0 |
31 Dec 17 | 521,482 | 17,699 | 71,465 | 0 |
30 Sep 17 | 527,284 | 8,061 | 70,920 | 0 |
30 Jun 17 | 486,341 | -1,810 | 66,921 | 0 |
31 Mar 17 | 492,401 | 8,476 | 67,041 | 0 |
31 Dec 16 | 500,540 | 11,056 | 65,864 | 0 |
30 Sep 16 | 537,314 | 16,873 | 74,210 | 0 |
30 Jun 16 | 558,894 | 18,550 | 73,925 | 0 |
31 Mar 16 | 551,996 | 12,112 | 77,610 | 0 |
31 Dec 15 | 531,573 | 15,505 | 78,002 | 0 |
30 Sep 15 | 485,991 | 8,869 | 63,688 | 0 |
30 Jun 15 | 490,885 | 14,182 | 64,908 | 0 |
31 Mar 15 | 468,306 | 13,856 | 58,477 | 0 |
31 Dec 14 | 472,835 | 14,600 | 56,195 | 0 |
30 Sep 14 | 457,643 | 21,313 | 57,659 | 0 |
30 Jun 14 | 446,291 | 21,678 | 54,869 | 0 |
31 Mar 14 | 421,055 | 17,822 | 51,500 | 0 |
31 Dec 13 | 392,316 | 15,994 | 49,036 | 0 |
Quality Earnings: SRSN has high quality earnings.
Growing Profit Margin: SRSN's current net profit margins (5.9%) are higher than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRSN's earnings have grown by 9.4% per year over the past 5 years.
Accelerating Growth: SRSN's earnings growth over the past year (14.1%) exceeds its 5-year average (9.4% per year).
Earnings vs Industry: SRSN earnings growth over the past year (14.1%) exceeded the Chemicals industry 13.7%.
Return on Equity
High ROE: SRSN's Return on Equity (8.5%) is considered low.